Innate Pharma S.A.
IPHA
Positions held
Your positionsIPHA isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $165.32M | Enterprise value | $147.99M | Trailing P/E | — | Forward P/E | -3.14 |
| PEG | — | Price / book | -3.04 | Beta | 1.19 | Dividend yield | 0.00% |
| Revenue growth | 16.5% | Earnings growth | — | Gross margin | 0.0% | Operating margin | -3.4% |
| Profit margin | 0.0% | ROE | — | ROA | -46.6% | Debt / equity | — |
| Current ratio | 0.60 | Free cash flow | -$28.96M | Analyst recommendation | none | Mean target | $6.67 |
| 52w high | $2.71 | 52w low | $1.17 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $2.8M | $12.6M | $51.9M | $49.6M |
| Op margin | -1916.9% | -408.7% | -24.4% | -33.1% |
| Net income | -$49.2M | -$49.5M | -$7.6M | -$58.1M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$53.4M | -$51.6M | -$12.7M | -$16.4M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Down 22% in 4 Weeks, Here's Why Innate Pharma (IPHA) Looks Ripe for a Turnaround
2026-10-05 · Down 25% in 4 Weeks, Here's Why You Should You Buy the Dip in Innate Pharma (IPHA)
2026-09-23 · Innate Pharma (IPHA) Upgraded to Buy: Here's What You Should Know
2026-09-23 · Innate Pharma (IPHA) Closes Sobi Deal. Can the New Funding Keep Drug Trials on Track?
2026-09-18 · Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript
2026-09-17 · Innate Pharma Q2 Earnings Call Highlights
2026-09-17 · Innate Pharma Reports First Half 2026 Business Update and Financial Results
2026-09-17 · Sobi and Innate announce partnership is now effective following completion of closing conditions
2026-09-16 · Innate Pharma, Sobi Partnership Becomes Effective
2026-09-16 · Innate and Sobi Announce Partnership Is Now Effective Following Completion of Closing Conditions
2026-09-02 · Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Price (daily)
Full chart · RSI · MACD · patterns